La taille du marché du traitement des maladies du foie devrait atteindre 6,94 milliards de dollars américains d’ici 2031, contre 4,41 milliards de dollars américains en 2023. Le marché devrait enregistrer un TCAC de 5,8 % au cours de la période 2023-2031. L’utilisation croissante de systèmes hybrides pour l’imagerie en raison des avantages offerts par rapport aux systèmes conventionnels restera probablement une tendance clé sur le marché.
Analyse du marché du traitement des maladies du foie
Le marché du traitement des maladies du foie est stimulé par la prévalence croissante des maladies du foie ainsi que par l’avancée technologique pour le traitement et le diagnostic de ces affections. Divers facteurs ont contribué à l’augmentation de la prévalence des maladies du foie, à l’augmentation de la consommation d’alcool, à la recrudescence des infections hépatiques telles que les hépatites A et B, à l’augmentation de l’incidence du cancer du foie, etc. De plus, la multiplication des collaborations et des partenariats entre les acteurs du marché pour le développement de nouvelles techniques de traitement et de diagnostic devrait contribuer davantage à la croissance globale du marché.
Aperçu du marché du traitement des maladies du foie
Liver disease treatment market is expected to grow moderately during the forecast period owing to the rising prevalence of liver diseases and technological advancements in imaging techniques. Additionally, surging collaboration and partnership among market players is likely to create ample opportunities however, the high cost of imaging techniques and stringent regulatory policies are expected to hamper the market growth. Furthermore, North America accounts for the major share followed by Europe, and Asia Pacific is expected to show significant growth over the next few years. North America consists of high developed countries with developed healthcare infrastructure along with high disposable income. Asia Pacific consists of developing countries with and increasing number of liver disease cases, government initiatives taken for liver treatment, and a rise in the development by the market players for the treatment of liver diseases. The change in the culture, lifestyle and consumption of alcohol is expected to increase the number of liver diseases number and eventually the market for liver treatment is anticipated to grow significantly.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Liver Disease Treatment Market: Strategic Insights
CAGR (2023 - 2031)5.8%- Market Size 2023
US$ 4.41 Billion - Market Size 2031
US$ 6.94 Billion
Market Dynamics
- Increasing Prevelance of liver diseases creates demnad for liver imaging
- Increasing collaborations and partnerships among market players leads to new product launches
- Increasing use of hybrid systems for imaging owing to the benefits offered as compared to the conventional systems
Key Players
- General Electric,
- Koninklijke Philips N.V.,
- Siemens AG,
- Canon Medical Systems Corporation,
- Hitachi, Ltd, Elekta AB (pub),
- Neusoft Corporation,
- Samsung Healthcare,
- BPL Medical Technologies,
- Cura Healthcare
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Diseases - Cirrhosis
- Hepatitis
- Cancer and Other Diseases
Imaging Modality - Magnetic Resonance Imaging
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Liver Disease Treatment Market Drivers and Opportunities
Increasing Prevalence of Liver Diseases to Favor Market Growth
There has been a significant rise in the number of liver diseases across the globe during the previous years. Various factors such as changing lifestyle patterns, diabetes, obesity, metabolic syndrome, and cardiovascular disorders have been leading to an increase in the cases of liver disease. According to National institute of Health, 2023 report, Liver disease accounts for 2 million deaths annually which is 4% of all deaths globally. Among various liver diseases, the cases of Alcoholic liver disease (ALD) is among the main causes of chronic liver disease worldwide. ALC accounts for 48% of cirrhosis associated deaths in the United States. Liver disease is considered to be the fifth reason cause of death in England & Wales, after heart, cancer, stroke and respiratory disease. Alcohol consumption is said to be a major factor leading to liver diseases among the population in the United States as well as UK. In the UK, alcohol consumption per person across the population has more than doubled in the last half-century. The rise in the number of liver diseases is expected to grow at a significant rate during the forecast period, hence fueling the growth of the market in the coming years.
Partnerships and Collaborations Between Market Players create ample Opportunities for the Market
In recent years, there have been various partnerships as well as collaborations among the players operating in the market. For instance, in January, 2024, Mindray North America, collaborated with Aegle Medical Solutions, to be the sole distributor of its Hepatus-Series Transient Elastography Diagnostic Ultrasound Systems for liver care. Additionally, in December 2023, Clarivate Plc launched VeriSIM Life Translational Index on Cortellis Drug Discovery Intelligence and this new solution is the next step of an intensifying partnership between Clarivate and VeriSIM Life. The integrated workflow provides customers with a multitude of predictive compound safety and efficacy insights, including bioavailability, hepatic and renal clearance, clinical toxicity, first-in-human dose and more. Partnerships and collaborations are considered to offer growth opportunities to the market players. Such growth strategies made by the companies are likely to offer significant growth opportunities for the market players operating in the liver treatment market during the forecast period.
Liver Disease Treatment Market Report Segmentation Analysis
Key segments that contributed to the derivation of the liver disease treatment market analysis are disease and imaging modality.
- Based on disease, the liver disease treatment market is segmented into cirrhosis, hepatitis, cancer and other diseases. The cancer segment held a largest market share in 2023.
- By imaging modality, the market is segmented into magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and other modalities. The computed tomography segment held the largest share of the market in 2023.
Analyse de la part de marché du traitement des maladies du foie par géographie
La portée géographique du rapport sur le marché du traitement des maladies du foie est principalement divisée en cinq régions : Amérique du Nord, Asie-Pacifique, Europe, Moyen-Orient et Afrique, et Amérique du Sud et centrale.
L’Amérique du Nord a dominé le marché en raison de l’incidence croissante des hépatites A, B et C, de l’augmentation du nombre de cancers du foie et de stéatose hépatique non alcoolique. Les développements des acteurs du marché dans le domaine des équipements d’imagerie diagnostique et la hausse de la consolidation du marché sont susceptibles de stimuler la croissance du marché du traitement des maladies du foie au cours de la période de prévision. En outre, la croissance du tourisme médical fait que le Mexique attire davantage de patients pour des traitements à moindre coût. La région devrait continuer à détenir le plus grand marché pour le traitement du foie dans un avenir proche. L’Asie-Pacifique devrait connaître la croissance avec le TCAC le plus élevé dans les années à venir.
Portée du rapport sur le marché du traitement des maladies du foie
| Attribut de rapport | Détails |
|---|---|
| Taille du marché en 2023 | 4,41 milliards de dollars américains |
| Taille du marché d’ici 2031 | 6,94 milliards de dollars américains |
| TCAC mondial (2023 - 2031) | 5,8% |
| Données historiques | 2021-2022 |
| Période de prévision | 2024-2031 |
| Segments couverts | Par maladies
|
| Régions et pays couverts | Amérique du Nord
|
| Leaders du marché et profils d’entreprises clés |
|
- L'exemple de PDF présente la structure du contenu et la nature des informations avec une analyse qualitative et quantitative.
Actualités et développements récents du marché du traitement des maladies du foie
Le marché du traitement des maladies du foie est évalué en collectant des données qualitatives et quantitatives après des recherches primaires et secondaires, qui comprennent d’importantes publications d’entreprise, des données d’association et des bases de données. Quelques-uns des développements sur le marché du traitement des maladies du foie sont répertoriés ci-dessous :
- La société a lancé QP-Liver, qui améliore le diagnostic des maladies hépatiques diffuses grâce à une quantification très précise de la graisse tissulaire et du fer à partir des examens IRM. Il a reçu les marques CE et UKCA respectivement pour l'Union européenne et le Royaume-Uni, ce qui signifie qu'il est autorisé à être utilisé sur ces marchés. (Source : Quibim, site Internet de l'entreprise, mars 2024)
- PerkinElmer Inc a lancé le système d'imagerie Vega, qui combine une technologie automatisée mains libres avec une capacité à haut débit pour accélérer la recherche non invasive et les études de développement de médicaments sur le cancer, les maladies du foie et des reins, la cardiologie et bien plus encore. (Source : AXIS IMAGING NEWS, Newsletter, avril 2022)
- Royal Philips a reçu l'autorisation 510(k) de la Food and Drug Administration (FDA) des États-Unis pour ses nouveaux outils de quantification des graisses hépatiques dans le cadre de la dernière version de ses systèmes à ultrasons EPIQ Elite et Affiniti, apportant les avantages de l'échographie en termes de coût et d'accessibilité à le diagnostic d’une maladie hépatique à un stade précoce. (Source : Royal Philips, communiqué de presse, novembre 2021)
Couverture et livrables du rapport sur le marché du traitement des maladies du foie
Le rapport « Taille et prévisions du marché du traitement des maladies du foie (2021-2031) » fournit une analyse détaillée du marché couvrant les domaines ci-dessous :
- Taille et prévisions du marché du traitement du foie aux niveaux mondial, régional et national pour tous les segments de marché clés couverts par le champ d’application
- Tendances du marché du traitement du foie ainsi que dynamiques du marché telles que les moteurs, les contraintes et les opportunités clés
- Analyse détaillée des cinq forces et SWOT de PEST/Porter
- Analyse du marché du traitement des maladies du foie couvrant les principales tendances du marché, le cadre mondial et régional, les principaux acteurs, les réglementations et les développements récents du marché
- Analyse du paysage de l’industrie et de la concurrence couvrant la concentration du marché, l’analyse de la carte thermique, les principaux acteurs et les développements récents du marché du traitement des maladies du foie
- Profils d'entreprises détaillés
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
North America Region is expected to dominate the liver disease treatment market in 2023.
The increasing prevalence of liver diseases and technological advancement in imaging techniques are the driving factors impacting the liver disease treatment market
Increasing use of hybrid systems for imaging over conventional systems are future trends of liver disease treatment market
Leading market players operating in the liver disease treatment market include General Electric, Koninklijke Philips N.V., Siemens AG, Canon Medical Systems Corporation, Hitachi, Ltd, Elekta AB (pub), Neusoft Corporation, Samsung Healthcare, BPL Medical Technologies, and Cura Healthcare.
The liver disease treatment market is expected to reach around US$ 6.94 Bn by the end of 2031
The Liver disease treatment is expected to grow at the CAGR of 5.8% during the forecast period.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For